Related Experiment Videos
[ABO blood group expression in corneal allograft failures]
N Ardjomand1, P Komericki, A Klein
1Universitäts-Augenklinik, Medizinische Universität, Graz, Osterreich. navid.ardjomand@meduni-graz.at
Summary
ABO blood group antigens are up-regulated in failed corneal allografts, particularly during immune-mediated rejection. This finding suggests a potential role for these antigens in corneal transplant rejection, impacting graft survival.
Area of Science:
- Ophthalmology
- Immunology
- Transplantation Biology
Background:
- Normal corneal epithelial cells express ABO blood group antigens.
- Inflamed corneas show antigen expression on stromal and endothelial cells.
- Corneal allograft failure is a significant clinical concern.
Purpose of the Study:
- To investigate ABO blood group antigen expression in failed corneal allografts.
- To determine if antigen expression differs between rejection and non-rejection graft failures.
- To explore the potential role of ABO antigens in corneal allograft rejection.
Main Methods:
- Examined 22 failed corneal allografts.
- Classified cases into immune-mediated rejection (12) and chronic endothelial cell loss (10).
- Used immunohistochemistry with monoclonal antibodies to detect A and B antigens.
Main Results:
- ABO antigens were expressed by stromal keratocytes (5/12) and endothelial cells (7/12) in grafts with rejection.
- Endothelial cells showed A/B antigen expression in 3/10 grafts with chronic endothelial cell loss.
- Upregulation of ABO antigens was observed in failed grafts, especially with rejection.
Conclusions:
- ABO blood group antigens can be upregulated in corneal allograft failure.
- Immune-mediated rejection is associated with increased ABO antigen expression.
- This upregulation may contribute to the process of corneal allograft rejection.